Market closed
Beyond Air/$XAIR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Beyond Air
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Ticker
$XAIR
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
107
Website
Beyond Air Metrics
BasicAdvanced
$32M
Market cap
-
P/E ratio
-$1.37
EPS
-0.18
Beta
-
Dividend rate
Price and volume
Market cap
$32M
Beta
-0.18
52-week high
$2.20
52-week low
$0.30
Average daily volume
1.2M
Financial strength
Current ratio
5.764
Quick ratio
4.463
Long term debt to equity
58.227
Total debt to equity
60.408
Interest coverage (TTM)
-15.01%
Management effectiveness
Return on assets (TTM)
-63.06%
Return on equity (TTM)
-202.66%
Valuation
Price to revenue (TTM)
7.632
Price to book
1.13
Price to tangible book (TTM)
1.19
Price to free cash flow (TTM)
-0.324
Growth
Revenue change (TTM)
685.91%
Earnings per share change (TTM)
-33.41%
3-year revenue growth (CAGR)
99.72%
3-year earnings per share growth (CAGR)
2.96%
What the Analysts think about Beyond Air
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Beyond Air stock.
Beyond Air Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Beyond Air Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Beyond Air News
AllArticlesVideos
National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products
GlobeNewsWire·3 weeks ago
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy
GlobeNewsWire·4 weeks ago
Beyond Air Receives CE Mark in Europe for the LungFit® PH System
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Beyond Air stock?
Beyond Air (XAIR) has a market cap of $32M as of December 31, 2024.
What is the P/E ratio for Beyond Air stock?
The price to earnings (P/E) ratio for Beyond Air (XAIR) stock is 0 as of December 31, 2024.
Does Beyond Air stock pay dividends?
No, Beyond Air (XAIR) stock does not pay dividends to its shareholders as of December 31, 2024.
When is the next Beyond Air dividend payment date?
Beyond Air (XAIR) stock does not pay dividends to its shareholders.
What is the beta indicator for Beyond Air?
Beyond Air (XAIR) has a beta rating of -0.18. This means that it has an inverse relation to market volatility.